Gastroenterology & GI Surgery

Welcome to the Mayo Clinic Gastroenterology & GI Surgery Page! With one of the largest group of digestive disease specialists in the world, Mayo Clinic has been recognized as the nation's best Gastroenterology & GI Surgery hospital by U.S. News & World Report.
Follow the page to read shared experiences, learn about clinical trials and up-to-date research, and find resources for all your gastroenterology needs. Our goal is to connect you to others, and become informed decision makers; so post a comment, share your story, own your health.

PUBLIC PAGE
Thu, Oct 11, 2018 11:20pm

Biologic Therapy in Pregnancy Does Not Affect Infant Vaccines

By Kanaaz Pereira, Connect Moderator, @kanaazpereira

People with inflammatory bowel disease (IBD)  like Crohn's or ulcerative colitis may need immunosuppressive biologic therapy to control the disease. Some of these drugs can cross the placenta and many pregnant women worry about the effect this may have on the baby. But multiple studies have found no link between using biologic agents and adverse pregnancy outcomes.

Dr. Sunanda Kane, M.D., goes further to explain a recent study, which found that the effectiveness of  vaccines given to infants does not appear to be affected by exposure to biologic therapy taken by mothers with IBD during pregnancy. The study was published in Clinical Gastroenterology and Hepatology.

For more information about IBD, visit mayoclinic.org/IBD

Dr. Kane is a gastroenterologist at Mayo Clinic.

Meet others talking about inflammatory bowel diseases (IBD) like Crohn's and ulcerative colitis on Mayo Clinic Connect – an online community where you can share experiences, ask questions, and find support from people like you.

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Gastroenterology & GI Surgery page.

We'll include this text in the user's invitation.